Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI

Susan M. Landau,Danielle Harvey,Cindee M. Madison,Robert A. Koeppe,Eric M. Reiman,Norman L. Foster,Michael W. Weiner,William J. Jagust,the Alzheimer's Disease Neuroimaging Initiative
DOI: https://doi.org/10.1016/j.neurobiolaging.2009.07.002
IF: 5.133
2011-07-01
Neurobiology of Aging
Abstract:The Functional Activities Questionnaire (FAQ) and Alzheimer's Disease Assessment Scale-cognitive subscale (ADAS-cog) are frequently used indices of cognitive decline in Alzheimer's disease (AD). The goal of this study was to compare FDG-PET and clinical measurements in a large sample of elderly subjects with memory disturbance. We examined relationships between glucose metabolism in FDG-PET regions of interest (FDG-ROIs), and ADAS-cog and FAQ scores in AD and mild cognitive impairment (MCI) patients enrolled in the Alzheimer's Disease Neuroimaging Initiative (ADNI). Low glucose metabolism at baseline predicted subsequent ADAS-cog and FAQ decline. In addition, longitudinal glucose metabolism decline was associated with concurrent ADAS-cog and FAQ decline. Finally, a power analysis revealed that FDG-ROI values have greater statistical power than ADAS-cog to detect attenuation of cognitive decline in AD and MCI patients. Glucose metabolism is a sensitive measure of change in cognition and functional ability in AD and MCI, and has value in predicting future cognitive decline.
neurosciences,geriatrics & gerontology,gerontology
What problem does this paper attempt to address?